[Stakes of pre-analytical parameters in blood transcriptomic and proteomic analysis. Application to clinical research: the GOELAMS trial].
暂无分享,去创建一个
Thierry Fest | François Berger | T. Fest | M. Béné | J. de Vos | F. Berger | John De Vos | M. Arlotto | Marie-Christine Béné | C. Pangault | Céline Pangault | Marie Arlotto
[1] Todd,et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.
[2] Ash A. Alizadeh,et al. Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[4] Graham B. I. Scott,et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.
[5] Jun Ma,et al. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. , 2006, The Journal of laboratory and clinical medicine.